WENTWORTH KERRY (Chief Regulatory Officer) sold 2.7% of their position (3.94K shares) of FLEXION THERAPEUTICS INC on the open market
Open‑market sale worth $25.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2021ACC: 0001209191-21-047504
Officer· Chief Regulatory Officer
Since Oct 2018
-3.94K
Net shares
Net seller
$25.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.94K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.94K
Price / share
$6.45
Trade value
$25.44K
% of position
2.7%
7/19/2021
144.31K→140.36K
Total
Net shares
−3.94K
Net value
-$25.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/19/2021 | S · Sale | −3.94K | $6.45 | $25.44K | 2.7% | 144.31K | 140.36K |
| Total | −3.94K | -$25.44K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6K
Total
6K indirect6K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6K | Indirect |
| Total | 6K | 6K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported